Integrative pathophysiology of solid tumors: role in detection and treatment.

Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques.

Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies.

Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism.

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

Tumor pretargeting for radioimmunodetection and radioimmunotherapy.

Fractal characteristics of tumor vascular architecture during tumor growth and regression.

Quantitative angiogenesis assays: progress and problems.

Effects of needle insertion in tumors on interstitial fluid pressure.

Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker.

Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications.

Transport of molecules across tumor vasculature.

Response of tumours to hyperglycaemia: characterization, significance and role in hyperthermia.

Determinants of tumor blood flow: a review.

Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching.

Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure.

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.

Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection.

Vascular permeability and interstitial diffusion of macromolecules in the hamster cheek pouch: effects of vasoactive drugs.

Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.

Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues.

Vascular and interstitial barriers to delivery of therapeutic agents in tumors.

Extravascular transport in normal and tumor tissues.

Tumor physiology and antibody delivery.

Effect of intravenous versus intraperitoneal glucose injection on systemic hemodynamics and blood flow rate in normal and tumor tissues in rats.

Transport of fluid and macromolecules in tumors. IV. A microscopic model of the perivascular distribution.

Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism.

Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation.

Measurement of capillary filtration coefficient in a solid tumor.

Therapeutic implications of tumor physiology.

Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response.

Haemodynamic and transport barriers to the treatment of solid tumours.

Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays.

Interstitial hypertension in head and neck tumors in patients: correlation with tumor size.

Tissue-isolated human tumor xenografts in athymic nude mice.

Fluorescence ratio imaging measurement of pH gradients: calibration and application in normal and tumor tissues.

Residence time distributions of various tracers in tumors: implications for drug delivery and blood flow measurement.

Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.

Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice.

Barriers to drug delivery in solid tumors.

Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.

Spatial heterogeneity in tumor perfusion measured with functional computed tomography at 0.05 microliter resolution.

Flow velocity in the superficial lymphatic network of the mouse tail.

A method for labeling cells for positron emission tomography (PET) studies.

Reduction of rigidity in human activated natural killer cells by thioglycollate treatment.

Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy.

2H-nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma.

Angiogenesis and growth of isografted bone: quantitative in vivo assay in nude mice.

Interaction of activated natural killer cells with normal and tumor vessels in cranial windows in mice.

In vivo pharmacokinetics of triazinate in L-1210 and W-256 cells.